Lung Transplant; Complications Clinical Trial
Official title:
Live Music Therapy to Reduce Anxiety, Pain and Improve Sleep in Post-Operative Lung Transplant Patients: A Pilot Study
Verified date | March 2024 |
Source | University of Texas Southwestern Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this prospective pilot study is to determine if live music therapy reduces patients' perception of pain and anxiety, reduces benzodiazepine use and pain medication use, length of stay in the ICU, and length of stay in hospital, and improves sleep in post-lung transplant patients. The purpose and objectives of the study are the following: - To determine if music therapist delivered patient preferred live music and therapeutic intervention will reduce participant's perceived anxiety in post-lung transplant patients. - To determine if music therapist delivered patient preferred live music and therapeutic intervention will reduce participant's perceived pain in post-lung transplant patients. - To determine if music therapist delivered patient preferred live music and therapeutic intervention in post-lung transplant patients will reduce participant's use of benzodiazepine medication for anxiety. - To determine if music therapist delivered patient preferred live music and therapeutic intervention three times in post-lung transplant patients will reduce participant's use of pain medication. - To determine if music therapist delivered patient preferred live music and therapeutic intervention in post-lung transplant patients will reduce participant's total time of intubation, length of stay in ICU, and length of stay in the hospital. - To determine if music therapist delivered patient preferred live music and therapeutic intervention will improve the quality and length of sleep in post-lung transplant patients.
Status | Active, not recruiting |
Enrollment | 64 |
Est. completion date | December 2024 |
Est. primary completion date | December 1, 2023 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - All post-lung transplant patients at UTSW Clements University Hospital starting June 1, 2021 Exclusion Criteria: - Post-lung transplant patients with chests left open directly after OR (before being taken back to the OR and having their chests closed) |
Country | Name | City | State |
---|---|---|---|
United States | University of Texas Southwestern Medical Center | Dallas | Texas |
Lead Sponsor | Collaborator |
---|---|
University of Texas Southwestern Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Anxiety levels | Comparing the scores from the Hamilton Anxiety Rating Scale (HAM-A) scale before and after music therapy. Scores range between 0-56 where <17 indicates mild severity, 18-24 mild to moderate severity and 25-30 moderate to severe. | Changes from baseline to post-surgery day 6 | |
Primary | Change in Pain levels (CPOT) | Comparing the scores from the Critical Care Pain Observation Tool (CPOT) scale before and after music therapy. Scores ranges between 0 (no pain) to 8 (maximum pain). | Changes from baseline to post-surgery day 6 | |
Primary | Change in Pain levels (Pain number scale) | Comparing the scores from the Pain number scale before and after music therapy. Scores ranges between 0 (no pain) to 10 (maximum pain). | Changes from baseline to post-surgery day 6 | |
Primary | Change in dosage of benzodiazepine medication | Comparing medication dosage between intervention group vs control group. | Changes from baseline to post-surgery day 6 | |
Primary | Change in dosage of pain medication | Comparing medication dosage between intervention group vs control group | Changes from baseline to post-surgery day 6 | |
Primary | Change in length of sleep | Comparing Fitbit data on length of sleep between intervention group vs control group | Changes from baseline to post-surgery day 6 | |
Primary | Change in length of stay in ICU and in hospital | Comparing length of stay between intervention group vs control group | Changes from baseline to post-surgery day 6 | |
Primary | Change in total time of intubation | Comparing duration of intubation between intervention group vs control group | Intubation prior to surgery until extubation (Post-surgery day 4) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05526950 -
Cytokine Filtration in Lung Transplantation: A Swedish National Study (GLUSorb)
|
N/A | |
Recruiting |
NCT05916495 -
An Evaluation of Remote Care (Questionnaire+Hybrid) in Patients Who Are Post-lung Transplant
|
N/A | |
Enrolling by invitation |
NCT05950724 -
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
|
Early Phase 1 | |
Active, not recruiting |
NCT05505422 -
Routine Versus Selective Intraoperative ECMO in Lung Transplant
|
N/A | |
Recruiting |
NCT05081141 -
HHV8 and Solid Organ Transplantation
|
||
Enrolling by invitation |
NCT04522388 -
Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant
|
N/A | |
Completed |
NCT04165161 -
Performance Diagnosis of a Patent Foramen Ovale During Lung Transplantation Using Transesophageal Echocardiography
|
N/A | |
Recruiting |
NCT05050955 -
AlloSure Lung Assessment and Metagenomics Outcomes Study
|
||
Withdrawn |
NCT03258801 -
Pirfenidone as Bridging Therapy for Lung Transplant in Patients Suffering From Idiopathic Pulmonary Fibrosis
|
||
Completed |
NCT04892719 -
4DX Functional Lung Imaging in the Diagnosis of Chronic Lung Allograft Dysfunction After Lung Transplantation
|
N/A | |
Completed |
NCT03221764 -
Intraoperative Amiodarone to Prevent Atrial Fibrillation in Lung Transplant Patients
|
Phase 2 | |
Completed |
NCT05116748 -
COVID19 Vaccine in SOT Adult Recipients
|
||
Recruiting |
NCT03367221 -
Physiological Response in Lung Transplant Recipients Undergoing Neurally Adjusted Ventilatory Assist
|
N/A | |
Recruiting |
NCT03276403 -
Primary Graft Dysfunction Score in Lung Transplantation
|
N/A | |
Active, not recruiting |
NCT03656926 -
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2)
|
Phase 3 | |
Completed |
NCT05242289 -
Cytokine Adsorption in Lung Transplantation
|
N/A | |
Recruiting |
NCT04837339 -
Diagnostic and Prognostic Biomarkers of Transplant Dysfunction in the Context of Lung Transplantation
|
N/A | |
Not yet recruiting |
NCT04377139 -
Management of Cytomegalovirus (CMV) Infection in Lung Transplant Recipients (LTR)
|
||
Not yet recruiting |
NCT06399302 -
Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes
|
||
Terminated |
NCT03562416 -
Continuation of Nintedanib After Single Lung Transplantation in IPF Subjects
|
Phase 2 |